SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART
Report
- Report Number
- 3003761017-2011-00010
- Event Type
- Injury
- Date Received
- April 12, 2011
- Date of Event
- March 19, 2011
- Report Date
- April 11, 2011
- Manufacturer
- SYNCARDIA SYSTEMS, INC.
- Product Code
- LOZ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA, US
- Reporter Occupation
- PHYSICIAN
Narratives
UPON INSPECTION, A SMALL LINEAR TEAR IN THE RIGHT VENTRICLE CANNULA WAS NOTED ABOVE THE CONNECTION SITE AND ADJACENT TO THE WIRE REINFORCED PORTION OF THE CANNULA. THIS TEAR ALLOWED AIR TO ESCAPE, RESULTING IN DECREASED FILL VOLUMES IN THE 30S. THE TEAR IN THE CANNULA WAS REPAIRED BY THE HOSPITAL BY SEALING IT WITH SUPER GLUE, ELIMINATING THE AIR LEAK. THE CANNULA WAS FURTHER REINFORCED WITH A SEGMENT OF 1/2" TUBING THAT WAS GLUED OVER THE AREA OF THE REPAIRED TEAR AND SECURED WITH TIE BANDS. AFTER THE AIR LEAK WAS REPAIRED, THE FILL VOLUMES RETURNED INTO THE UPPER 50S WITH A CARDIAC OUTPUT OF SEVEN LITERS/MINUTE. THE CUSTOMER REPORTED THAT THERE WAS NO ADVERSE IMPACT ON THE PT. SYNCARDIA HAS REQUESTED THAT THE TAH-T AND CANNULA BE RETURNED TO SYNCARDIA FOR EVAL AFTER THE PT HAS BEEN TRANSPLANTED. THE RESULTS OF THE EVAL WILL BE PROVIDED IN A SUPPLEMENTAL MDR.
PT (B)(6) WAS IMPLANTED WITH THE SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART (TAH-T) ON (B)(6) 2010. HE WAS TRANSFERRED FROM THE CIRCULATORY SUPPORT SYSTEM (CSS) CONSOLE TO THE INVESTIGATIONAL FREEDOM DRIVER SYSTEM ON (B)(6) 2011. THE PT REPORTED THAT SHORTLY AFTER THE DRIVER TRANSFER, HE BEGAN TO NOTICE INTERMITTENT "HISSING" OF AIR THAT OCCURRED WHEN HE CHANGED HIS BODY POSITION. ON (B)(6), THE PT BEGAN TO EXPERIENCE LOW FILL VOLUMES, FOLLOWED BY INTERMITTENT FREEDOM DRIVER FAULT ALARMS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SYNCARDIA TEMPORARY TOTAL ARTIFICIAL HEART | ARTIFICIAL HEART | LOZ | SYNCARDIA SYSTEMS, INC. | TAH-T | 069303 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 33 YR | Required Intervention |